Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01
Published May 7, 2025 · Recall initiated: April 21, 2025
Summary
FDA records drug Class II recall D-0389-2025, published May 7, 2025 and initiated April 21, 2025. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 18,867 bags; Lot: Lot #: 3TF24002A, Exp 11/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
What to do
Voluntary: Firm initiated · Letter
Get an email if TIROFIBAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TIROFIBAN
- Manufacturer
- Eugia US LLC
- Distributor
- USA nationwide.
- UPC
- 0355150430017
- Lot
- Lot #: 3TF24002A, Exp 11/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only,May 7, 2025
- FDAClindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark PharmaceuticalsMay 7, 2025
- FDADexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single DoseMay 7, 2025
- FDAThe Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers included inApril 30, 2025
- FDASkytron Freedom 4FXS-60 Heavy Duty Monitor MountApril 30, 2025
- FDABrand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-01 Software Version: AllApril 30, 2025
Questions about this recall
Was Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01 recalled?
Yes. FDA published recall D-0389-2025 on May 7, 2025. Reported hazard: Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TIROFIBAN. UPC: 0355150430017.